Apart from growth retardation, the CD19 KO cells showed no CXCL12-induced migration, highlighting the critical role of CD19 in maintaining B-cell lymphoma viability and mobility (Figure 1F–H). Here, CXCL12 is linked to B-cell non-Hodgkin lymphoma.